
Sign up to save your podcasts
Or


IC editor John Hughman is joined by Harriet Russell and Megan Boxall to discuss whether Sainsbury's swoop on Asda will leave shareholders in the money, and why a wave of M&A could also be about to hit the global pharmaceutical industry.
Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.
Investors' Chronicle is a service by the Financial Times.
Hosted on Acast. See acast.com/privacy for more information.
By Investors' Chronicle3.7
77 ratings
IC editor John Hughman is joined by Harriet Russell and Megan Boxall to discuss whether Sainsbury's swoop on Asda will leave shareholders in the money, and why a wave of M&A could also be about to hit the global pharmaceutical industry.
Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.
Investors' Chronicle is a service by the Financial Times.
Hosted on Acast. See acast.com/privacy for more information.

1,233 Listeners

52 Listeners

43 Listeners

77 Listeners

1,335 Listeners

589 Listeners

37 Listeners

88 Listeners

267 Listeners

50 Listeners

115 Listeners

17 Listeners

1,181 Listeners

840 Listeners

137 Listeners

1,026 Listeners

113 Listeners

12 Listeners

14 Listeners

4 Listeners

194 Listeners

50 Listeners

194 Listeners

12 Listeners

34 Listeners